It is a leader in the warp knitting industry and plans to enter the medical device field. Hongda Warp is a leading enterprise in China's warp editing industry. In June 2009, the company announced plans to issue 44 million shares to acquire 100% of the shares of Shenzhen Wilder Medical Electronics Co., Ltd. The additional issuance plan was conditionally approved by the Securities Regulatory Commission's restructuring committee on February 25. Shenzhen Welder is one of the important B-ultrasound equipment manufacturers in China. It is mainly committed to the R&D, production and sales of handheld, portable, and trolley-type B-ultrasound instruments, and has strong technical strength. The textile business began to improve. The company is a leading enterprise in the automotive roof fabric industry. The automotive interior fabric business is the company's main source of profit. Driven by the downstream automobile industry, the 2009 revenue growth rate was 37.4% year-on-year, and it is expected to maintain high growth this year. Businesses such as elastic fabrics and trade are expected to remain stable. Shenzhen Weilde will enter a period of rapid growth. China's B-ultrasound diagnostic equipment market continues to expand, and is in a stage of steady development of expanding from a medium-sized market to a large-scale market. In the new medical reform plan, it is clearly proposed to strengthen the construction of primary medical institutions. The black and white ultrasound and color ultrasound in Wilder's products are mainly adding supporting medical equipment to the construction of township hospitals and county hospitals supported by the state, respectively. Prior to 2009, Shenzhen Welder's products were all black and white. It is expected that this part of the business will maintain a growth rate of more than 20% in the future, while the lottery products launched at the end of 2009 will greatly increase the profitability of Shenzhen Wilde. Currently, the promotion of Super League is going smoothly, and Shenzhen Wilder will enter a period of rapid growth. In the future, we will stick to the dual main business of warp knitting, textile, and medical equipment. After successfully acquiring Shenzhen Weilde, Hongda will stick to the development of the textile and medical device industries. In the textile sector, the company will continue to develop high-margin products by adjusting the product structure, and will not seek to expand in scale; in the medical device field, it will use Shenzhen Wilde as a platform to further expand and strengthen listed companies by going hand in hand with the two main industries to expand and strengthen listed companies. Currently, the stock price is marginal at a safe margin. According to the calculation of 44 million additional shares, the total share capital of the company after the additional issuance is completed is 151,3388 million shares. We expect Hongda's main textile business to contribute 0.18 yuan and 0.21 yuan in EPS in 2010 and 2011, respectively; Shenzhen Wilde's 2010 and 2011 EPS contributions were 0.29 yuan and 0.46 yuan respectively; the company's 10.33 million shares of Haining Picheng shares are equivalent to 2.5 yuan per share. The company's current stock price is only 14.73 yuan, and Shenzhen Wilde is on a high margin of safety. A period of growth, so an investment rating of “Highly Recommended” was given. Risk warning. The company has received final approval from the Securities Regulatory Commission, and the timing for completing the integration is uncertain.